Indo Us Biotech Limited has informed the Exchange about General Updates Confirmation regarding not falling under the Large Corporate
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Biotech Limited has informed the stock exchanges that it does not meet any of the criteria to be classified as a 'Large Corporate' under SEBI's November 2018 circular on fund raising by issuance of debt securities. This is a routine annual/periodic compliance confirmation required from all listed companies. Large Corporate status applies to companies meeting specific thresholds related to borrowings and outstanding debt, and such entities have additional obligations to raise a minimum portion of their borrowings through the debt market. By confirming it does not qualify, the company is essentially stating it is too small to fall under these stricter requirements.
This is a routine compliance disclosure with no material impact on shareholders or stock price. It simply confirms the company is below the Large Corporate threshold, meaning it has no additional mandatory debt-market fundraising obligations under SEBI rules.